Technology
MADISON SQUARE GARDEN ENTERTAINMENT CORP. REPORTS FISCAL 2025 FIRST QUARTER RESULTS
Published
2 years agoon
By
NEW YORK, Nov. 8, 2024 /PRNewswire/ — Madison Square Garden Entertainment Corp. (NYSE: MSGE) (“MSG Entertainment” or the “Company”) today reported financial results for the fiscal first quarter ended September 30, 2024.
Since the start of fiscal 2025, the Madison Square Garden Arena (“The Garden”) has hosted a record number of concerts for a fiscal first quarter and, last month, welcomed back the New York Knicks (“Knicks”) and the New York Rangers (“Rangers”) for the start of their 2024-25 regular seasons at The Garden. Later today, the Christmas Spectacular production kicks off its 2024 holiday season at Radio City Music Hall with 199 performances currently on sale as compared to 193 shows in fiscal 2024. In addition, new sales and renewal activity in the Company’s premium hospitality business remains strong, while the Company also recently announced new multi-year sponsorship deals with Lenovo and its subsidiary Motorola Mobility and the Department of Culture and Tourism – Abu Dhabi, as well as a multi-year extension of its sponsorship deal with Verizon.
For the fiscal 2025 first quarter, the Company reported revenues of $138.7 million, a decrease of $3.5 million, or 2%, as compared to the prior year quarter. In addition, the Company reported an operating loss of $18.5 million, an improvement of $14.9 million, or 45%, and adjusted operating income of $1.9 million, an increase of $2.1 million, both as compared to the prior year quarter.(1)
Executive Chairman and CEO James L. Dolan said, “With fiscal ’25 underway, we expect our portfolio of assets and brands to continue benefiting from demand for shared experiences, including this year’s Christmas Spectacular production. Looking ahead, we remain confident in the strength of our Company and believe we are well positioned to generate long-term value for our shareholders.”
Results for the Three Months Ended September 30, 2024 and 2023:
Three Months Ended
September 30,
Change
$ millions
2024
2023
$
%
Revenues
$ 138.7
$ 142.2
$ (3.5)
(2) %
Operating Loss
$ (18.5)
$ (33.4)
$ 14.9
45 %
Adjusted Operating Income (Loss)(1)
$ 1.9
$ (0.2)
$ 2.1
NM
Note: Amounts may not foot due to rounding. NM – Absolute percentages greater than 200% and comparisons from positive to negative values or to zero values are not considered meaningful.
(1)
See page 3 of this earnings release for the definition of adjusted operating income (loss) (“AOI”) included in the discussion of non-GAAP financial measures. During the fiscal 2024 third quarter, the Company amended this definition so that the non-cash portion of operating lease revenue related to the Company’s Arena License Agreements with Madison Square Garden Sports Corp. (“MSG Sports”) is no longer excluded in all periods presented. For the three months ended September 30, 2024 and the three months ended September 30, 2023, the non-cash portion of operating lease revenue was $0.5 million.
Entertainment Offerings, Arena License Fees and Other Leasing
Fiscal 2025 first quarter revenues from entertainment offerings of $115.1 million decreased $1.4 million, or 1%, as compared to the prior year period, primarily due to lower event-related revenues.
Event-related revenues decreased $1.5 million, primarily due to lower revenues from concerts. This reflects lower per-concert revenues primarily due to a shift in the mix of events at The Garden from promoted events to rentals and a decrease in the number of concerts at the Company’s theaters, partially offset by an increase in the number of concerts at The Garden.
Fiscal 2025 first quarter arena license fees and other leasing revenues of $4.7 million increased $2.2 million, or 90%, as compared to the prior year period, due to an increase in other leasing revenues.
Fiscal 2025 first quarter direct operating expenses associated with entertainment offerings, arena license fees and other leasing of $86.5 million decreased $4.1 million, or 5%, as compared to the prior year quarter, primarily due to lower event-related expenses of $3.5 million. The decrease in event-related expenses was primarily due to lower expenses from concerts, mainly driven by lower per-concert expenses due to a shift in the mix of events at The Garden from promoted events to rentals, partially offset by an increase in the number of events at The Garden.
Food, Beverage and Merchandise
Fiscal 2025 first quarter food, beverage and merchandise revenues of $19.0 million decreased $4.3 million, or 18%, as compared to the prior year period. This was primarily due to lower food and beverage sales at concerts held at the Company’s venues as compared to the prior year quarter, primarily due to lower per-concert food and beverage revenues and, to a lesser extent, the decrease in the number of events at the Company’s theaters, partially offset by the increase the number of events at The Garden.
Fiscal 2025 first quarter food, beverage and merchandise direct operating expenses of $11.2 million increased $0.1 million, or 1%, as compared to the prior year period.
Selling, General and Administrative Expenses
Fiscal 2025 first quarter selling, general and administrative expenses of $45.7 million decreased $3.1 million, or 6%, as compared to the prior year period. The decrease was primarily due to (i) lower professional fees, mainly due to the absence of non-recurring costs incurred by the Company in the prior year period in connection with the registration and sale of the Company’s Class A common stock by Sphere Entertainment Co.; (ii) a decrease in employee compensation and benefits; and (iii) lower other costs, all as compared to the prior year period. These decreases were partially offset by higher rent expense as compared to the prior year period.
Operating Loss and Adjusted Operating Income (Loss)
Fiscal 2025 first quarter operating loss of $18.5 million improved $14.9 million, or 45%, as compared to the prior year period, primarily due to lower restructuring charges and, to a lesser extent, the decrease in direct operating expenses and selling, general and administrative expenses, partially offset by the decrease in revenues. Fiscal 2025 first quarter adjusted operating income of $1.9 million increased $2.1 million as compared to the prior year quarter, primarily due to lower direct operating expenses and selling, general and administrative expenses (excluding merger, spin-off and acquisition-related costs), partially offset by the decrease in revenues.
About Madison Square Garden Entertainment Corp.
Madison Square Garden Entertainment Corp. (MSG Entertainment) is a leader in live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The Company’s portfolio includes a collection of world-renowned venues – New York’s Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre – that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the Company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for more than 90 years. More information is available at www.msgentertainment.com.
Non-GAAP Financial Measures
During the fiscal 2024 third quarter the Company amended its definition of adjusted operating income so that the impact of the non-cash portion of operating lease revenue related to the Company’s Arena License Agreements with MSG Sports is no longer excluded in all periods presented.
We define adjusted operating income (loss), which is a non-GAAP financial measure, as operating income (loss) excluding (i) depreciation, amortization and impairments of property and equipment, goodwill and other intangible assets, (ii) share-based compensation expense or benefit, (iii) restructuring charges or credits, (iv) merger, spin-off, and acquisition-related costs, including merger-related litigation expenses, (v) gains or losses on sales or dispositions of businesses and associated settlements, (vi) the impact of purchase accounting adjustments related to business acquisitions, (vii) amortization for capitalized cloud computing arrangement costs and (viii) gains and losses related to the remeasurement of liabilities under the executive deferred compensation plan. We believe that the exclusion of share-based compensation expense or benefit allows investors to better track the performance of the various operating units of our business without regard to the settlement of an obligation that is not expected to be made in cash. We eliminate merger, spin-off, and acquisition-related costs, when applicable, because the Company does not consider such costs to be indicative of the ongoing operating performance of the Company as they result from an event that is of a non-recurring nature, thereby enhancing comparability. In addition, management believes that the exclusion of gains and losses related to the remeasurement of liabilities under the executive deferred compensation plan, provides investors with a clearer picture of the Company’s operating performance given that, in accordance with U.S. generally accepted accounting principles, gains and losses related to the remeasurement of liabilities under the executive deferred compensation plan are recognized in Operating (income) loss whereas gains and losses related to the remeasurement of the assets under the executive deferred compensation plan, which are equal to and therefore fully offset the gains and losses related to the remeasurement of liabilities, are recognized in Other income (expense), net, which is not reflected in Operating income (loss).
We believe adjusted operating income (loss) is an appropriate measure for evaluating the operating performance of the Company on a consolidated and combined basis. Adjusted operating income (loss) and similar measures with similar titles are common performance measures used by investors and analysts to analyze our performance. Internally, we use revenues and adjusted operating income (loss) as the most important indicators of our business performance, and evaluate management’s effectiveness with specific reference to these indicators. Adjusted operating income (loss) should be viewed as a supplement to and not a substitute for operating income (loss), net income (loss), cash flows from operating activities, and other measures of performance and/or liquidity presented in accordance with GAAP. Since adjusted operating income (loss) is not a measure of performance calculated in accordance with GAAP, this measure may not be comparable to similar measures with similar titles used by other companies. For a reconciliation of operating income (loss) to adjusted operating income (loss), please see page 5 of this release.
Forward-Looking Statements
This press release may contain statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that any such forward-looking statements are not guarantees of future performance or results and involve risks and uncertainties, and that actual results, developments or events may differ materially from those in the forward-looking statements as a result of various factors, including financial community perceptions of the Company and its business, operations, financial condition and the industries in which it operates and the factors described in the Company’s filings with the Securities and Exchange Commission, including the sections titled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained therein. The Company disclaims any obligation to update any forward-looking statements contained herein.
Contacts:
Ari Danes, CFA
Senior Vice President, Investor Relations, Financial Communications & Treasury
Madison Square Garden Entertainment Corp.
(212) 465-6072
Justin Blaber
Vice President, Financial Communications
Madison Square Garden Entertainment Corp.
(212) 465-6109
Grace Kaminer
Vice President, Investor Relations & Treasury
Madison Square Garden Entertainment Corp.
(212) 631-5076
Sarah Rothschild
Senior Director, Investor Relations & Treasury
Madison Square Garden Entertainment Corp.
(212) 631-5345
Conference Call Information:
The conference call will be Webcast live today at 8:30 a.m. ET at investor.msgentertainment.com
Conference call dial-in number is 888-660-6386 / Conference ID Number 8020251
Conference call replay number is 800-770-2030 / Conference ID Number 8020251 until November 15, 2024
Investor presentation available at investor.msgentertainment.com/events-and-presentations
MADISON SQUARE GARDEN ENTERTAINMENT CORP.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(Unaudited)
Three Months Ended
September 30,
2024
2023
Revenues
Revenues from entertainment offerings
$ 115,081
$ 116,505
Food, beverage, and merchandise revenues
18,975
23,261
Arena license fees and other leasing revenue
4,658
2,446
Total revenues
138,714
142,212
Direct operating expenses
Entertainment offerings, arena license fees, and other leasing direct operating expenses
(86,466)
(90,559)
Food, beverage, and merchandise direct operating expenses
(11,243)
(11,118)
Total direct operating expenses
(97,709)
(101,677)
Selling, general, and administrative expenses
(45,746)
(48,822)
Depreciation and amortization
(13,781)
(13,585)
Restructuring credits (charges)
40
(11,553)
Operating loss
(18,482)
(33,425)
Interest income
372
851
Interest expense
(14,043)
(14,287)
Other expense, net
(769)
(4,469)
Loss from operations before income taxes
(32,922)
(51,330)
Income tax benefit
13,601
659
Net loss
$ (19,321)
$ (50,671)
Loss per share attributable to MSG Entertainment’s stockholders:
Basic and diluted
$ (0.40)
$ (1.00)
Weighted-average number of shares of common stock:
Basic and diluted
48,217
50,437
MADISON SQUARE GARDEN ENTERTAINMENT CORP.
ADJUSTMENTS TO RECONCILE OPERATING INCOME (LOSS) TO
ADJUSTED OPERATING INCOME (LOSS)
(in thousands)
(Unaudited)
The following is a description of the adjustments to operating loss in arriving at adjusted operating income (loss) as described in this earnings release:
Depreciation and amortization. This adjustment eliminates depreciation and amortization of property and equipment and intangible assets.Share-based compensation. This adjustment eliminates the compensation expense relating to restricted stock units and stock options granted under the Company’s Employee Stock Plan and the Company’s Non-Employee Director Plan.Restructuring charges. This adjustment eliminates costs related to termination benefits provided to certain corporate executives and employees.Merger, spin-off, and acquisition-related costs. This adjustment eliminates costs related to mergers, spin-offs and acquisitions, including merger-related litigation expenses.Amortization for capitalized cloud computing arrangement costs. This adjustment eliminates amortization of capitalized cloud computing arrangement costs.Remeasurement of deferred compensation plan liabilities. This adjustment eliminates the impact of gains and losses related to the remeasurement of liabilities under the executive deferred compensation plan.
Three Months Ended
September 30,
$ thousands
2024
2023
Operating loss
$ (18,482)
$ (33,425)
Depreciation and amortization
13,781
13,585
Share-based compensation (excluding share-based compensation included in restructuring charges)
6,262
6,177
Restructuring (credits) charges
(40)
11,553
Merger, spin-off, and acquisition-related costs (1)
—
2,035
Amortization for capitalized cloud computing arrangement costs
168
—
Remeasurement of deferred compensation plan liabilities
220
(145)
Adjusted operating income (loss) (2)
$ 1,909
$ (220)
(1)
This adjustment represents non-recurring costs incurred and paid by the Company for the sale of the retained interest by Sphere Entertainment Co.
(2)
During the fiscal 2024 third quarter the Company amended the definition of adjusted operating income so that the non-cash portion of operating lease revenue related to the Company’s Arena License Agreements with MSG Sports is no longer excluded in all periods presented. Pursuant to GAAP, recognition of operating lease revenue is recorded on a straight-line basis over the term of the agreement based upon the value of total future payments under the arrangement. As a result, operating lease revenue is comprised of a contractual cash component plus or minus a non-cash component for each period presented. Adjusted operating income includes operating lease revenue of (i) $854 and $829 of revenue collected in cash for the three months ended September 30, 2024 and September 30, 2023, respectively, and (ii) a non-cash portion of $470 and $495 for the three months ended September 30, 2024 and September 30, 2023, respectively.
MADISON SQUARE GARDEN ENTERTAINMENT CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)
(Unaudited)
September 30,
2024
June 30,
2024
ASSETS
Current Assets:
Cash, cash equivalents, and restricted cash
$ 37,613
$ 33,555
Accounts receivable, net
95,525
77,259
Related party receivables, current
20,768
17,469
Prepaid expenses and other current assets
106,490
90,801
Total current assets
260,396
219,084
Non-Current Assets:
Property and equipment, net
642,338
633,533
Right-of-use lease assets
391,058
388,658
Goodwill
69,041
69,041
Indefinite-lived intangible assets
63,801
63,801
Deferred tax assets, net
81,733
68,307
Other non-current assets
101,960
110,283
Total assets
$ 1,610,327
$ 1,552,707
LIABILITIES AND DEFICIT
Current Liabilities:
Accounts payable, accrued and other current liabilities
$ 159,261
$ 203,750
Related party payables, current
43,671
42,506
Long-term debt, current
20,313
16,250
Operating lease liabilities, current
27,014
27,736
Deferred revenue
270,955
215,581
Total current liabilities
521,214
505,823
Non-Current Liabilities:
Long-term debt, net of deferred financing costs
646,975
599,248
Operating lease liabilities, non-current
451,071
427,014
Other non-current liabilities
39,765
43,787
Total liabilities
1,659,025
1,575,872
Commitments and contingencies
Deficit:
Class A Common Stock (a)
460
456
Class B Common Stock (b)
69
69
Additional paid-in-capital
26,909
33,481
Treasury stock at cost (4,365 shares outstanding as of September 30, 2024 and June 30, 2024)
(140,512)
(140,512)
Retained earnings
96,282
115,603
Accumulated other comprehensive loss
(31,906)
(32,262)
Total deficit
(48,698)
(23,165)
Total liabilities and deficit
$ 1,610,327
$ 1,552,707
(a)
Class A Common Stock, $0.01 par value per share, 120,000 shares authorized; 45,958 and 45,556 shares issued as of September 30, 2024 and June 30, 2024, respectively.
(b)
Class B Common Stock, $0.01 par value per share, 30,000 shares authorized; 6,867 shares issued as of September 30, 2024 and June 30, 2024.
MADISON SQUARE GARDEN ENTERTAINMENT CORP.
SELECTED CASH FLOW INFORMATION
(in thousands)
(Unaudited)
Three Months Ended
September 30,
2024
2023
Net cash (used in) provided by operating activities
$ (27,359)
$ 1,378
Net cash used in investing activities
(6,690)
(55,490)
Net cash provided by financing activities
38,107
9,273
Net increase (decrease) in cash, cash equivalents, and restricted cash
4,058
(44,839)
Cash, cash equivalents, and restricted cash, beginning of period
33,555
84,355
Cash, cash equivalents, and restricted cash, end of period
$ 37,613
$ 39,516
View original content to download multimedia:https://www.prnewswire.com/news-releases/madison-square-garden-entertainment-corp-reports-fiscal-2025-first-quarter-results-302299640.html
SOURCE Madison Square Garden Entertainment Corp.
You may like
Technology
ProjectDiscovery Introduces Neo Triage, Replacing Static Risk Scores with Proven Exploitability
Published
1 second agoon
October 26, 2026By
Neo Triage reproduces every scanner, bug bounty and AI-generated finding against the real asset, then sets severity from proven impact
SAN FRANCISCO, Oct. 26, 2026 /PRNewswire/ — ProjectDiscovery, a leader in vulnerability detection and autonomous security testing, today announced the general availability of Neo Triage: a new capability in its Neo platform that validates every incoming security finding by safely reproducing it against the live asset. Every verdict comes with the exact requests and responses that prove it, so teams can go straight to fixing what’s real.
Neo Triage gives every team one place to triage findings from every source, including:
Dynamic triage: Runs safe, non-destructive tests from an isolated sandbox to reproduce each finding against the live assetVerdicts with evidence: Marks every finding valid, duplicate, needs more information, informative, not applicable or spam, and attaches the exact requests and responses as proofSeverity from proven impact: Sets severity from the impact Neo proved and from the asset’s context, including the data behind it, how exposed it is and what else it reachesOne queue for every source: Pulls findings from HackerOne, GitHub security advisories, security mailboxes, Wiz, Qualys, Orca and any other tool with an API onto one boardFix and retest: Suggests a fix, drafts a reply to the researcher and retests automatically once the fix shipsInsights: Tracks open backlog, SLA status, time to zero, weekly remediation and the quality of each source
“Today, AI has made finding vulnerabilities cheap, and security teams spend hours reproducing each finding by hand,” said Rishi Sharma, CEO and Co-founder of ProjectDiscovery. “In the next 6-12 months, triage and the bottleneck it causes will be the biggest problem security teams will face. Scanners, AI code review and AI-assisted bug hunting now generate findings faster than teams can review them, leaving most organizations with thousands – or even millions, of open findings. The hard part now is deciding which findings matter, and a score can’t make that decision. Proof can. Neo Triage tests every finding against the real asset and hands the team a verdict with the evidence attached, so teams spend their time on decisions instead of on reproducing reports.”
Manual triage takes anywhere from 15 minutes to four hours per finding. ProjectDiscovery estimates that for a 100,000-finding backlog, Neo Triage turns roughly 50,000 hours of manual work, the equivalent of 25 people for a year, into about 8,300 hours of verdict review. Every Neo tier – including its free, community tier – includes the full Triage product.
Neo itself is free to get started, with monthly usage included and no time limit. Anyone can sign up and run useful workflows immediately, whether that means triaging findings from their own scanners or running a prompt that checks whether they’re exposed to a newly disclosed vulnerability. As their usage grows, teams can move to Pro or Enterprise tiers under zero data retention.
For more information on Neo Triage, visit: https://projectdiscovery.io/blog/introducing-neo-triage
About ProjectDiscovery
ProjectDiscovery is an open source cybersecurity company that built the security toolchain trusted by more than 100,000 practitioners worldwide. The company created Nuclei, the most widely used open source vulnerability scanner with over 10 billion scans run, along with a suite of modular tools including Subfinder, httpx, and Naabu that security teams use to map attack surfaces and identify exploitable vulnerabilities. Building on that foundation, ProjectDiscovery offers Neo, an AI-powered security testing platform that unifies SAST, DAST, and automated penetration testing to help teams move from finding vulnerabilities to verifying and fixing them. ProjectDiscovery is a winner of the RSAC Innovation Sandbox 2025 and a Black Hat Asia 2025 award recipient. Learn more at projectdiscovery.io.
View original content to download multimedia:https://www.prnewswire.com/news-releases/projectdiscovery-introduces-neo-triage-replacing-static-risk-scores-with-proven-exploitability-302918866.html
SOURCE ProjectDiscovery
Technology
Corgi Insurance Appoints Morgan Bevin as VP, Public Affairs Officer
Published
3 seconds agoon
October 26, 2026By
SAN FRANCISCO, Oct. 26, 2026 /PRNewswire/ — Corgi, an AI-native insurance carrier and financial infrastructure company, today announced the appointment of Morgan Bevin as VP, Public Affairs Officer. Bevin will help lead Corgi’s government affairs efforts, working at the intersection of insurance, financial services, and emerging technology as the company continues to expand its insurance offerings and infrastructure.
Bevin joins Corgi from Sternhell Group, where she served as Principal, advising clients on government relations across financial services and technology. Her work spans public policy, regulatory strategy, and government affairs for financial institutions, technology companies, and organizations across the financial services sector.
Prior to Sternhell Group, Bevin was a Consultant at Wachsman, providing strategic advisory and communications services to financial services and emerging technology companies. She also served as a Professional Staff Member on the U.S. House of Representatives Committee on Financial Services, where she helped lead the Committee’s financial technology agenda. Earlier in her career, she was a Financial Services Policy Fellow for Representative French Hill (AR-02).
Bevin’s background in financial services policy and government relations comes as Corgi continues to build modern insurance infrastructure for businesses navigating increasingly complex risks. As AI reshapes the insurance industry, Corgi is focused on developing technology-driven underwriting and insurance products while engaging with the regulatory and policy landscape surrounding the sector.
“We’re excited to have Morgan join Corgi as we continue to grow our business and expand our presence across the insurance industry,” said Jeremy Eisemann, Chief External Affairs Officer and Deputy General Counsel at Corgi. “Her experience across government, financial services, and emerging technology will be valuable as we work with policymakers and industry stakeholders to support the next generation of insurance.”
About Corgi
Corgi Insurance is an AI-native insurance carrier and financial infrastructure company. The company combines proprietary underwriting technology, modern insurance infrastructure, and in-house claims capabilities to provide coverage for businesses across a growing range of industries.
Media Contact:
Corgi Press
press@corgi.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/corgi-insurance-appoints-morgan-bevin-as-vp-public-affairs-officer-302918837.html
SOURCE Corgi
Technology
MEPSGEN Launches NanoCalibur® Mini for Small-Volume Nanoparticle Formulation
Published
5 seconds agoon
October 26, 2026By
Automated system enables rapid, reproducible formulation screening with minimal sample consumptionCompletes the NanoCalibur® Series (Mini, Lab, Pro, GMP), supporting a seamless scale-up path from early research to GMP manufacturing
BOSTON, Oct. 26, 2026 /PRNewswire/ — MEPSGEN US, Inc., a global innovator in drug delivery system platforms, today announced the launch of NanoCalibur® Mini, an automated system for small-volume nanoparticle formulation designed for early-stage drug discovery and development.
Nanoparticles are delivery vehicles that carry therapeutic payloads to target sites in the body, and they are central to next-generation modalities such as mRNA and gene therapies. Early-stage research requires repeated testing of many raw materials and process conditions, so the ability to generate fast, consistent results from limited material is essential.
NanoCalibur® Mini formulates lipid nanoparticles (LNPs) and polymeric nanoparticles at volumes of 0.1–3 mL. Built on MEPSGEN‘s proprietary microfluidic technology, it delivers precise, stable microfluidic flow control for rapid and highly reproducible formulation. Researchers can choose between two single-use microfluidic cartridges, 0.1–0.4 mL and 0.4–3 mL, to match their application, from early formulation screening through a range of preclinical studies. By enabling many formulation conditions to be tested quickly with minimal material, Mini helps accelerate development timelines while reducing reagent consumption and experimental costs.
One production architecture, from discovery to GMP
With the addition of Mini, the NanoCalibur® Series now spans four systems (Mini, Lab, Pro, and GMP), allowing customers to select the right platform for their development stage and production scale.
The defining feature of the series is a consistent formulation environment at every scale. NanoCalibur® Mini to Lab and to GMP uses the same microfluidic mixing pattern, with the same structure and dimensions. Rather than redesigning the mixer or changing the formulation conditions as production grows, NanoCalibur® increases throughput by parallelizing identical mixing units. This design is intended to reduce the need for process re-optimization during scale-up and technology transfer, while preserving nanoparticle quality and batch-to-batch reproducibility.
Protecting payload integrity at scale
In large-scale nanoparticle manufacturing, the high flow rates required for throughput can generate shear forces that damage sensitive payloads such as mRNA and reduce the potency. The NanoCalibur® Series is engineered to maintain stable shear conditions as production scales, helping preserve payload integrity and deliver consistent nanoparticle quality. More importantly, preserving payload potency will have the high potential to reduce the dose required for therapeutic effect, possibly addressing the high-dosage toxicity such as LNPs.
Launch promotion
To mark the launch of NanoCalibur® Mini, MEPSGEN will run a series of promotional offers through the end of the year for research institutions and pharmaceutical and biotechnology companies evaluating the system. Details will be announced on the MEPSGEN website and the company’s official LinkedIn page.
“With NanoCalibur® Mini, we have extended our product lineup so that we can support customers more precisely at every stage, from early research through GMP manufacturing,” said YongTae Kim, CEO of MEPSGEN. “We will continue to broaden the applications and customer base of the NanoCalibur® Series and strengthen our position in the global nanomedicine manufacturing market.”
About MEPSGEN
MEPSGEN is a biotech company headquartered in Seoul, South Korea, with office in Cambridge, MA. The company was co-founded in 2019 by current CEO YongTae (Tony) Kim and Professor Robert Langer from MIT, a world-renowned expert in drug delivery and biomaterials who has pioneered numerous breakthroughs in controlled-release systems.
The company specializes in microphysiological system (MPS) and drug delivery system platforms based on its proprietary microfluidics technology. Its NanoCalibur® Series offers scalable nanoparticle formulation systems that support drug discovery, preclinical research, and GMP manufacturing, while its MPS platforms, including the MEPS-X Series and ProMEPS®, recreate the physiological function of human organs for New Approach Methodologies (NAMs). Together, they help pharmaceutical and biotech companies, universities, hospitals, and research institutions improve the efficiency and success rate of drug development.
For more information, please visit www.mepsgen.com or reach out to info@mepsgen-us.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/mepsgen-launches-nanocalibur-mini-for-small-volume-nanoparticle-formulation-302916579.html
SOURCE MEPSGEN US, Inc.
ProjectDiscovery Introduces Neo Triage, Replacing Static Risk Scores with Proven Exploitability
Corgi Insurance Appoints Morgan Bevin as VP, Public Affairs Officer
MEPSGEN Launches NanoCalibur® Mini for Small-Volume Nanoparticle Formulation
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology3 days agoMiami Startup BOB Raises $5.5M To Build An AI-Powered Banking Platform
-
Technology4 days agoVoqalize Says Voice Is Becoming the Default Way People Use Software
-
Technology4 days agoSnapmaker Introduces New Filament Bundle, Expanding Its Full Spectrum Printing Ecosystem
-
Coin Market4 days agoBitcoin ETFs bag another $528M, taking 3-day haul past $1B
-
Technology4 days agoPRC-Saltillo Acquires Ner Chat, Bringing Minspeak® Symbols to Glint Visual Support Platform
-
Technology4 days agoNew GASA Research: 71% of Adults Surveyed Across 13 Asian Markets Encountered Scams, with Estimated Losses of US$136.5 Billion
-
Technology5 days ago
New program to grow the Yukon’s forestry and bioenergy sector
-
Coin Market3 days agoCysic dangles a 10% bounty, hacker pours loot into Tornado Cash
